Intellipharmaceutics International Inc. (IPCI)

[doogdilinger]

The most glaring thing that pizzes most off is that as s/h's we were all led to believe that IPCI was definitely seeking a partner on Rexista...only to discover that when no partner was secured after many many months that IPCI's supposed new strategy was to go it alone right through FDA approval then seek a partner.

To me that just made the Rexista adcom disaster a sure fire failure that resulted in a mass exodus from this stock and the lingering negative market sentiment that remains...because without a big partner on Rexista or Regabatin...the past 4 years of generics results have been largely disappointing despite YOY revenue growth finally kicking in this year.

Had IPCI already secured big partnership deals on their 2 NDA's the year over year revenue growth finally kicking in from just 2 now fully commercialized ANDA's would be viewed in a much more positive light.

But right now the market continues to doubt IPCI's/Dr Odidi's proprietary hyper-matrix delivery tech platforms and the validity of the nPODDS and PODRAS technologies. Both could be potential game changers...but all the while neither have been proven...the generics pipeline alone will be viewed by and large as a disappointment despite some decent YOY revenue growth finally kicking in.

2016=$2M
2017=$6M at least
2018=$12M at least